Editorial Board
Yi Sui
Shenyang First People's Hospital, Shenyang Brain Institute · China
Editorial leadership for Journal of Current Chronic Diseases
Research interests
- Inflammatory Mechanism Of Pathogenesis In Neurodegenerative Diseases
- Chemokine-Induced Pathogenesis
- Chemokine-Regulated Neurogenesis In Neurodegenerative Diseases
Biography
- I have graduated from Dalian Medical University, China with a MBBS degree.
- After 6 years of resident doctor career in China, I went to The University of Melbourne to pursue higher research degree.
- My PhD project was to investigate the inflammatory mechanism of Parkinson's Disease.
- We have revealed that meloxicam, a preferentially selective COX-2 inhibitor, attenuates dopaminergic neuronal loss in the substantial nigra pars compacts in LPS-induced rats brain, by inhibiting microglial activation.
- From my 2nd year on of my PhD, I had switched to study neurogenesis in the adult brains.
- Employing 6-OHDA lesioned mice and cholecystokinin-1 receptor ablated mice, we have shown neurogenesis is regulated by cellular feedback in the olfactory system.
- My recent research interest has been focusing on the chemokine-induced pathogenesis and chemokine-regulated neurogenesis in neurodegenerative diseases.
Selected publications
- Knowledge domain and emerging trends in Alzheimer’s disease: a scientometric review based on CiteSpace analysis 2019 cited 189×
- Intravenous Alteplase Versus Best Medical Therapy for Patients With Minor Stroke: A Systematic Review and Meta-Analysis 2024 cited 29×
- Prognostic prediction of m6A and ferroptosis-associated lncRNAs in liver hepatocellular carcinoma 2024 cited 29×
- Tenecteplase thrombolysis for stroke up to 24 hours after onset with perfusion imaging selection: the umbrella phase IIa CHABLIS-T randomised clinical trial 2024 cited 20×
- Low-dose versus standard-dose alteplase in acute ischemic stroke in Asian stroke registries: an individual patient data pooling study 2019 cited 19×
- Prognostic Value of Serum Cardiac Troponin in Acute Ischemic Stroke: An Updated Systematic Review and Meta-Analysis 2022 cited 19×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JCD for your work?
This journal is guided by Yi Sui (Shenyang First People's Hospital, Shenyang Brain Institute) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.